Marianne Grønlie Guren

12PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsRadiation therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 20, 2026
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

|Mar 15, 2026
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer.

Stelios Theophanous, Per-Ivar Lønne, Ananya Choudhury

|Mar 02, 2026
Optimal time for MRI response evaluation in squamous cell carcinoma of the anus.

Bettina A Hanekamp, Ellen Viktil, Johann Baptist Dormagen

|May 15, 2025
Improving our understanding of the quality of life of patients with metastatic or recurrent/persistent anal cancer: a systematic review.

Samantha C Sodergren, Rowan Edwards, Rahul Krishnatry

|Jul 28, 2023
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer.

Martin P Nilsson, Christine Undseth, Per Albertsson

|Dec 02, 2021
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.

Julian Hamfjord, Tor Åge Myklebust, Inger Kristin Larsen

Pageof 2

Frequent Collaborators

2 joint publications

Ane Appelt

2 joint publications

Bengt Glimelius

2 joint publications

Tormod K Guren

2 joint publications

Eirik Malinen